ARRY has announced a significant partnership with a leading biotech company, likely enhancing its market position. With positive drug trial results and expected revenue growth from new approvals, investors may see improved sentiment and stock performance in the near future.
Clean energy stocks rose after tax removal from Senate bill. NextEra Energy and AES saw share increases of nearly 3% and 2%. Array Technologies' shares jumped over 11% amidst the positive news. The tax removal was seen as a relief by renewable energy advocates. Concerns remain about the overall impact of the legislation on clean energy.
Senate GOP proposes tax increases on clean energy projects. New taxes may burden renewable energy industry by $4-$7 billion. Phasing out critical tax credits threatens 300 gigawatts of projects. Construction sector faces 2 million job losses if legislation passes. Shares of solar stocks, including Array Technologies, have fallen.
U.S. stock futures rose, with the Dow gaining over 200 points. Array Technologies (ARRY) dropped 3.7% to $6.20 in pre-market. ARRT closed its upsized offering of 2.875% convertible senior notes. Other stocks, especially Tesla, showed mixed reactions in pre-market. Economic conditions reflect fluctuating investor sentiments impacting overall market.
House Republicans passed a tax bill ending key clean energy credits. Array's stock fell 14% due to fears over reduced demand. Credit terminations impact utility-scale solar project expansions significantly. Analysts believe Senate may modify the legislation favorably. First Solar remains relatively unscathed due to maintained manufacturing credits.
Citi upgrades Array Technologies to Buy from Neutral. Lowered revenue estimate for 2025, cut price target to $14. Array stock jumped 7.6% following positive industry news. Investors worried about near-term challenges, but long-term growth intact. Company expected to maintain 30% gross margin in 2025.